1. Home
  2. SWBI vs GLUE Comparison

SWBI vs GLUE Comparison

Compare SWBI & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWBI
  • GLUE
  • Stock Information
  • Founded
  • SWBI 1852
  • GLUE 2019
  • Country
  • SWBI United States
  • GLUE United States
  • Employees
  • SWBI N/A
  • GLUE N/A
  • Industry
  • SWBI Ordnance And Accessories
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SWBI Industrials
  • GLUE Health Care
  • Exchange
  • SWBI Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • SWBI 429.0M
  • GLUE 351.2M
  • IPO Year
  • SWBI N/A
  • GLUE 2021
  • Fundamental
  • Price
  • SWBI $7.74
  • GLUE $4.79
  • Analyst Decision
  • SWBI Buy
  • GLUE Buy
  • Analyst Count
  • SWBI 2
  • GLUE 2
  • Target Price
  • SWBI $12.00
  • GLUE $13.50
  • AVG Volume (30 Days)
  • SWBI 887.0K
  • GLUE 448.5K
  • Earning Date
  • SWBI 09-04-2025
  • GLUE 08-11-2025
  • Dividend Yield
  • SWBI 6.72%
  • GLUE N/A
  • EPS Growth
  • SWBI N/A
  • GLUE N/A
  • EPS
  • SWBI 0.30
  • GLUE 0.08
  • Revenue
  • SWBI $474,661,000.00
  • GLUE $159,487,000.00
  • Revenue This Year
  • SWBI N/A
  • GLUE $49.02
  • Revenue Next Year
  • SWBI $9.23
  • GLUE N/A
  • P/E Ratio
  • SWBI $25.80
  • GLUE $63.88
  • Revenue Growth
  • SWBI N/A
  • GLUE 14889.38
  • 52 Week Low
  • SWBI $7.74
  • GLUE $3.50
  • 52 Week High
  • SWBI $16.53
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • SWBI 31.68
  • GLUE 40.93
  • Support Level
  • SWBI $7.88
  • GLUE $5.22
  • Resistance Level
  • SWBI $8.36
  • GLUE $5.64
  • Average True Range (ATR)
  • SWBI 0.22
  • GLUE 0.38
  • MACD
  • SWBI 0.00
  • GLUE -0.11
  • Stochastic Oscillator
  • SWBI 1.32
  • GLUE 0.68

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: